WalkerR.H.: Noninfectious risks and new trends in transfusion practice.J Fla Med Assoc, 80: 37–38, 1993.
4.
VamvakasE.C.PinedaA.A.ReisnerR.SantrachP.J.MooreS.B.: The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis.Transfusion, 35: 26–32, 1995.
5.
NessP.M.ShireyR.S.ThomasS.K.BuckS.A.: The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long-term serologic findings, and clinical significance.Transfusion, 30: 688–693, 1990.
6.
SazamaK.: Reports of 355 transfusion-associated deaths: 1976 through 1985.Transfusion, 30: 583–590, 1990.
7.
WilliamsonL.M.LoweS.LoveE.M.CohenH.SoldanK.McClellandD.B.SkacelP.BarbaraJ.A.: Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports.Br Med J, 319: 16–19, 1999.
8.
PopovskyM.A.: Transfusion-related acute lung injury.In: Transfusion reactions, PopovskyM.A. (Ed), pp 167–183, American Association of Blood Banks Press, Bethesda, 1996.
9.
HeddleN.M.KlamaL.SingerJ.RichardsC.FedakP.WalkerI.KeltonJ.G.: The role of the plasma from platelet concentrates in transfusion reactions.N Engl J Med, 331: 625–628, 1994.
10.
GoodnoughL.T.RiddellJ4th, LazarusH.ChafelT.L.PrinceG.HendrixD.YomtovianR.: Prevalence of platelet transfusion reactions before and after implementation of leukocyte-depleted platelet concentrates by filtration.Vox Sang, 65: 103–107, 1993.
FederowiczI.BarrettB.B.AndersenJ.W.UrashimaM.PopovskyM.A.AndersonK.C.: Characterization of reactions after transfusion of cellular blood components that are white cell reduced before storage.Transfusion, 36: 21–28, 1996.
13.
KellyD.L.ManginiJ.Lopez-PlazaI.TriulziD.J.: The utility of < or = 3-day-old whole-blood platelets in reducing the incidence of febrile nonhemolytic transfusion reactions.Transfusion, 40: 439–442, 2000.
14.
AyeM.T.PalmerD.S.GiuliviA.HashemiS.: Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage.Transfusion, 35: 117–124, 1995.
15.
WadhwaM.SeghatchianM.J.DilgerP.ContrerasM.ThorpeR.: Cytokine accumulation in stored red cell concentrates: effect of buffy-coat removal and leucoreduction.Transfus Sci, 23: 7–16, 2000.
16.
ChalandonY.MermillodB.BerisP.DoucetA.ChapuisB.Roux-LombardP.DayerJ.M.: Benefit of prestorage leucocyte depletion of single-donor platelet concentrates.Vox Sang, 76: 27–37, 1999.
17.
PattersonB.J.FreedmanJ.BlanchetteV.SherG.PinkertonP.HannachB.MeharchandJ.LauW.BoyceN.PinchefskyE.TasevT.PinchefskyJ.PoonS.ShulmanL.MacKP.ThomasK.BlanchetteN.GreenspanD.PanzarellaT.: Effect of pre-medication guidelines and leukoreduction on the rate of febrile nonhemolytic platelet transfusion reactions.Transfus Med, 10: 199–206, 2000.
18.
EckrichR.J.MalloryD.M.SandlerS.G.: Laboratory tests to exclude IgA deficiency in the investigation of suspected anti-IgA transfusion reactions.Transfusion, 33: 1–5, 1993.
19.
PopovskyM.A.MooreS.B.: Diagnostic and pathogenetic considerations in transfusion-related acute lung injury.Transfusion, 25: 573–577, 1985.
20.
SillimanC.C.PatersonA.J.DickeyW.O.StroneckD.F.PopovskyM.A.CaldwellS.A.AmbrusoD.R.: The association of biologically active lipids with the development of transfusion-related acute lung injury.Transfusion, 37: 719–726, 1997.
21.
BoshkovL.SillimanC.ClarkeG.: Transfusion-related acute lung injury following platelet transfusion: a study of possible etiologic factors.Blood, 86(suppl): 354a, 1995.
22.
SillimanC.C.: Transfusion-related acute lung injury.Transfus Med Rev, 13: 177–186, 1999.
SillimanC.C.VoelkelN.F.AllardJ.D.ElziD.J.TuderR.M.JohnsonJ.L.AmbrusoD.R.: Plasma and lipids from stored packed red cells cause acute lung injury in an animal model.J Clin Invest, 101: 1458–1467, 1998.
25.
SillimanC.C.ElziD.J.HiesterA.A.: Plasma from stored platelets and red cells activate human pulmonary endothelium.Transfusion, 38(suppl): 96S, 1998.
VamvakasE.C.PinedaA.A.: Allergic and anaphylactic reactions.In: Transfusion reactions, PopovskyM.A. (Ed), pp 81–124, American Association of Blood Banks Press, Bethesda, 1996.
29.
HathawayW.E.BrangleR.W.NelsonT.L.RoeckelI.E.: Aplastic anemia and alymphocytosis in an infant with hypogammaglobulinemia: graft-versus-host?J Pediatr, 68: 713–722, 1966.
30.
AndersonK.C.: Clinical indications for blood component irradiation.In: Irradiation of blood components, BaldwinML, JefferiesLC (Eds), pp 31–49, American Association of Blood Banks Press, Bethesda, 1992.
31.
BCSH Blood Transfusion Task Force: Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease.Transfus Med, 6: 261–271, 1996.
32.
GellyK.J.KerrR.RawlinsonS.NorrisA.BowenD.T.: Transfusion-associated graft vs host disease in a patient with high-grade B-cell lymphoma. Should cellular products for patients with non-Hodgkin's lymphoma be irradiated?Br J Haematol, 110: 228–229, 2000.
33.
KleinH. (Ed): Standards for blood banks and transfusion services, 17th edn, American Association of Blood Banks Press, Bethesda, 1996.
34.
GrassJ.A.WafaT.ReamesA.WagesD.CorashL.FerraraJ.L.LinL.: Prevention of transfusion-associated graft-versus-host disease by photochemical treatment.Blood, 93: 3140–3147, 1999.